Fig. 5From: Pharmacological inhibition of EZH2 disrupts the female germline epigenomeH3K27me3 was not recovered in oocytes after treatment of fetal ovaries with tazemetostat. Data summary from flow cytometric analyses of E11.5 XX gonads cultured for 24 h with DMSO (green), 100 nM or 1 μM tazemetostat (Blue), followed by drug removal and additional culture for 48 h in the presence of DMSO (green), 100 nM or 1 μM tazemetostat. Drugs were removed by washes with culture media after the initial 24 h of culture. Four treatment groups were used to collect control and experimental data. Treatment 1: DMSO/DMSO—24 h DMSO followed by 48 h DMSO (negative control). Treatment 2: TAZ—24 h tazemetostat (H3K27me3 depletion after 24 h drug treatment). Treatment 3: TAZ/DMSO—24 h tazemetostat followed by 48 h DMSO (H3K27me3 recovery after 48 h drug withdrawal). Treatment 4: TAZ/TAZ—24 h tazemetostat followed by 48 h tazemetostat (H3K27me3 depletion after 72 h drug treatment). a Summary of experimental pipeline for assessing H3K27me3 recovery after drug depletion in germ cells undergoing epigenetic reprogramming. b Average H3K27me3 staining intensity in germ cells for treatments 1–4 DMSO/DMSO, TAZ, TAZ/DMSO and TAZ/TAZ using 1 μM (left) and 100 nM (right) tazemetostat from cultured E11.5 XX female gonads (1 μM, n = 5 biological replicates, 100 nM n = 4 biological replicates). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; one-way ANOVA plus post hoc Tukey’s multiple comparisons test. Error bars ± SEMBack to article page